Protective effect of loratadine on specific conjunctival provocation test.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  International Archives of Allergy and Applied Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000235519PMID 1687320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen.

  1990cited by this paper
• Conjunctival provocation test as a model for the study of allergy and inflammation in humans.

  1989cited by this paper
• Loratadine, an antihistamine, blocks antigen-and ionophore-induced leukotriene release from human lung in vitro.

  1988cited by this paper
• Inflammatory changes in conjunctival scrapings after allergen provocation in humans.

  1988cited by this paper
• Antiallergic activity of loratadine, a non‐sedating antihistamine

  1987cited by this paper
• Terfenadine reduces skin and conjunctival reactivity in grass pollen allergic children

  1986cited by this paper
• The Precision of the Conjunctival Provocation Test

  1984cited by this paper
• Eye tests with inhalant allergens; their feasibility, indications, and clinical value.

  1959cited by this paper

• Progress of Research and Comparative Analysis on the Combination of Mast Cell Stabilizers and Antihistamines in Allergic Conjunctivitis Treatment

  2025cites this paper
• KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy

  2023cites this paper
• Allergy Diagnosis

  2017cites this paper
• Ocular Allergy: an Updated Review

  2017cites this paper
• 54 – Allergic and Immunologic Eye Disease

  2016cites this paper
• Efficacy and Tolerability of Newer Antihistamines in the Treatment of Allergic Conjunctivitis

  2012cites this paper
• Chapter 5: Allergic rhinitis.

  2012cites this paper
• What has the relief of allergic conjunctivitis by intranasal steroids taught us about the pathophysiology of allergic rhinoconjunctivitis

  2009cites this paper
• Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids

  2008cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update

  2008cites this paper
• Ocular allergy treatment.

  2008cites this paper
• The diagnosis and management of rhinitis: an updated practice parameter.

  2008cites this paper
• RONDE DE LA SFO « ALLERGIES EN OPHTALMOLOGIE » Les tests de provocation conjonctivaux

  2007cites this paper
• Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.

  2007cites this paper
• Les tests de provocation conjonctivaux

  2007cites this paper
• [Conjunctival provocation test].

  2007cites this paper
• Pharmacotherapy of allergic eye disease

  2006cites this paper
• Pharmacology of ocular allergy

  2006cites this paper
• Protective effects of deflazacort on allergen-specific conjunctival challenge

  2005cites this paper
• Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.

  2003cites this paper
• Topical immunopharmacology of ocular allergies

  2002cites this paper
• Conjunctival provocation testing: overview of recent clinical trials in ocular allergy

  2002cites this paper
• Update on ocular allergy treatment

  2002cites this paper
• Conjunctival provocation testing: overview of recent clinical trials in ocular allergy.

  2002cites this paper
• Ocular allergy treatments

  2001cites this paper
• Allergic rhinitis and its impact on asthma.

  2001cites this paper
• International Conference on Allergic Rhinitis in Childhood

  1999cites this paper
• [Value of the conjunctival provocation test in evaluating the activity of 2 concentrations of anti-allergy eyedrops, mequitazine].

  1998cites this paper
• Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients

  1998cites this paper
• Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI+cells

  1997cites this paper
• Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis

  1997cites this paper
• Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.

  1997cites this paper
• Optimal Use of Topical Agents for Allergic Conjunctivitis

  1997cites this paper
• Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM‐1 expression

  1997cites this paper
• Antihistamines: topical vs oral administration

  1996cites this paper
• Quantification of conjunctival vascular reaction by digital imaging.

  1996cites this paper
• Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis.

  1995cites this paper
• Evaluation of a composite scoring system in conjunctival challenge with allergen: reproducibility and evolution during loratadine treatment

  1995cites this paper
• Loratadine

  1994cites this paper
• Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure.

  1994cites this paper
• Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.

  1994cites this paper
• A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients

  1994cites this paper
• Deflazacort protects against late‐phase but not early‐phase reactions induced by the allergen‐specific conjunctival provocation test

  1993cites this paper
• Precision of conjunctival provocation tests in right and left eyes.

  1993cites this paper
• Protective effect of loratadine on late phase reaction induced by conjunctival provocation test.

  1993cites this paper
• Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge.

  1993cites this paper
• Grass pollen and asthma.

  1992cites this paper